Using collagenase to treat Dupuytren’s disease: a hypothetical cost benefit analysis
**Background**: Dupuytren’s disease is a disorder of abnormal collagen production that may manifest in the palmar fascia. Treatment options vary according to clinical circumstances but surgical fasciectomy remains the gold standard. Collagenase, an enzyme produced by clostridium histolyticum (CCH),...
| 出版年: | Australasian Journal of Plastic Surgery |
|---|---|
| 主要な著者: | , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Australian Society of Plastic Surgeons
2019-03-01
|
| オンライン･アクセス: | https://doi.org/10.34239/ajops.v2i1.42 |